Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population. - Vuilleumier N; Antiochos P; Marques-Vidal P; Pagano S; Virzi J; Satta N; Hartley O; Gaertner H; Brandt KJ; Burger F; Montecucco F; Waeber G; et al. (Clinical & translational immunology, 2020)